Related Experiment Video
Updated: Jun 14, 2025

Mouse Models of Periventricular Leukomalacia
Published on: May 18, 2010
PLEKHG1: New Potential Candidate Gene for Periventricular White Matter Abnormalities
Francesco Calì1, Mirella Vinci1, Simone Treccarichi1
1Oasi Research Institute-IRCCS, 94018 Troina, Italy.
Insights
A genetic variant in the PLEKHG1 gene may cause periventricular leukomalacia (PVL), a condition linked to cerebral palsy. This study identifies a de novo PLEKHG1 variant in a PVL patient, suggesting a new genetic cause for this brain damage.
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- Periventricular leukomalacia (PVL) is a significant cause of neurological deficits like cerebral palsy, particularly in preterm infants.
- PVL results from compromised cerebral microcirculation, leading to oxygen deprivation in the brain's white matter.
- Known causes include preterm birth, cotwin demise, and genetic factors affecting GTPase pathways.
Purpose of the Study:
- To investigate the potential role of the PLEKHG1 gene in the pathogenesis of periventricular leukomalacia (PVL).
- To identify and characterize genetic variants associated with PVL.
- To explore the molecular mechanisms linking PLEKHG1 to white matter damage.
Main Methods:
- Whole exome sequencing (WES) was employed to identify genetic variants in a patient with PVL.
- In silico analyses were performed to predict the pathogenicity of the identified variant.
- Literature review and pathway analysis were used to understand the functional role of PLEKHG1 and CDC42.
Main Results:
- A de novo pathogenic variant in the PLEKHG1 gene was identified in a patient with PVL.
- PLEKHG1 encodes a Rho guanine nucleotide exchange factor crucial for CDC42 activation.
- The PLEKHG1-CDC42 pathway is implicated in endothelial cell responses to mechanical stress, potentially contributing to white matter lesions.
Conclusions:
- The identified de novo PLEKHG1 variant is a plausible contributor to PVL, expanding the genetic landscape of this condition.
- Disruption of the PLEKHG1-CDC42 pathway may underlie white matter damage in PVL.
- Further research is warranted to fully elucidate the role of PLEKHG1 in neonatal brain injury.
Abstract:
Hypoxic-ischemic brain damage presents a significant neurological challenge, often manifesting during the perinatal period. Specifically, periventricular leukomalacia (PVL) is emerging as a notable contributor to cerebral palsy and intellectual disabilities. It compromises cerebral microcirculation, resulting in insufficient oxygen or blood flow to the periventricular region of the brain. As widely documented, these pathological conditions can be caused by several factors encompassing preterm birth (4-5% of the total cases), as well single cotwin abortion and genetic variants such as those associated with GTPase pathways. Whole exome sequencing (WES) analysis identified a de novo causative variant within the pleckstrin homology domain-containing family G member 1 (PLEKHG1) gene in a patient presenting with PVL. The PLEKHG1 gene is ubiquitously expressed, showing high expression patterns in brain tissues. PLEKHG1 is part of a family of Rho guanine nucleotide exchange factors, and the protein is essential for cell division control protein 42 (CDC42) activation in the GTPase pathway. CDC42 is a key small GTPase of the Rho-subfamily, regulating various cellular functions such as cell morphology, migration, endocytosis, and cell cycle progression. The molecular mechanism involving PLEKHG1 and CDC42 has an intriguing role in the reorientation of cells in the vascular endothelium, thus suggesting that disruption responses to mechanical stress in endothelial cells may be involved in the formation of white matter lesions. Significantly, CDC42 association with white matter abnormalities is underscored by its MIM phenotype number. In contrast, although PLEKHG1 has been recently associated with patients showing white matter hyperintensities, it currently lacks a MIM phenotype number. Additionally, in silico analyses classified the identified variant as pathogenic. Although the patient was born prematurely and subsequently to dichorionic gestation, during which its cotwin died, we suggest that the variant described can strongly contribute to PVL. The aim of the current study is to establish a plausible association between the PLEKHG1 gene and PVL.
More Related Videos
Related Concept Videos
Pleiotropy
Neurulation

